Scientific News Is Boston Scientific Bsx Priced Right A Comprehensive Guide To Its Market Value
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Is Boston Scientific Bsx Priced Right A Comprehensive Guide To Its Market Value is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Is Boston Scientific (BSX) one of the best healthcare AI stocks to buy now?
Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare AI stocks to buy now. On December 12, TD Cowen reaffirmed a Buy rating on Boston Scientific Corporation (NYSE:BSX) and kept a ... Read More
Is Boston Scientific Corp. (BSX) positioned for solid, durable growth?
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index ... Read More
Boston Scientific: Gangbusters Growth, And A Valuation To Match
Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX stock here. Read More
BTIG Reiterates Boston Scientific (BSX) Buy Recommendation

As of November 17, 2025, the average one-year price target for Boston Scientific is $128.25/share. The forecasts range from a low of $102.46 to a high of $147.00. The average price target represents ... Read More
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 5.86% on an annualized basis producing an average annual return of 18.39%. Currently, Boston Scientific has a market ... Read More
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?

Boston Scientific Corp. (NYSE:BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on ... Read More
Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost

Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More
M&A Strategy Strengthens Boston Scientific's Growth Prospects

Over the past several years, Boston Scientific BSX has pursued a series of acquisitions in support of its growth strategy, both strengthening its core businesses and expanding into high-growth ... Read More
UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings

Boston Scientific Corporation (NYSE:BSX) ranks among the best long-term stocks to buy according to D. E. Shaw. On October 23, UBS maintained its Buy rating on Boston Scientific Corporation (NYSE:BSX) ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus

